ABS 1230
Alternative Names: ABS-1230Latest Information Update: 26 Sep 2025
At a glance
- Originator Actio Biosciences
- Class Antiepileptic drugs; Small molecules
- Mechanism of Action KCNT1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Epilepsy